lly glp 1 drug Eli Lilly (LLY): GLP-1 Dominance, AI Discovery FDA asks Lilly for more
Description
Effective Weight Loss: Significant and sustained weight loss when used as part of a comprehensive weight management plan
Bowel Obstruction: Studies show a link between Trulicity and an increased risk of bowel obstruction, particularly for those new to the medication (had been taking the drug for less than one month)
doi: 10.1111/bph.13549
& Derkinderen, P
Differential activation and modulation of the glucagon-like peptide-1 receptor by small molecule ligands
[DOI] [PubMed] [Google Scholar] 31.Kopp K.O., Glotfelty E.J., Li Y., Greig N.H
